Profiel
Robin Ali is currently a Professor at UCL Institute of Ophthalmology.
Previously, he held the position of Head-Preclinical Ophthalmology at MeiraGTx Holdings Plc and served as the President of the European Society of Gene & Cell Therapy.
He obtained his undergraduate degree from University College London in 1988 and his doctorate degree from the same institution in 1993.
Actieve functies van Robin Ali
| Bedrijven | Functie | Begin |
|---|---|---|
UCL Institute of Ophthalmology
UCL Institute of Ophthalmology Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Eerdere bekende functies van Robin Ali
| Bedrijven | Functie | Einde |
|---|---|---|
European Society of Gene & Cell Therapy | President | 28-10-2024 |
| MEIRAGTX HOLDINGS PLC | Corporate Officer/Principal | - |
Opleiding van Robin Ali
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Society of Gene & Cell Therapy | |
UCL Institute of Ophthalmology
UCL Institute of Ophthalmology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MeiraGTx Holdings Plc
MeiraGTx Holdings Plc BiotechnologyHealth Technology Develops and manufactures genetic medicines | Health Technology |
















